Prevention & lipids

Assessing Differences Between Epigenetic versus Chronologic Age for Cardiovascular Risk Assessments in the United States

Circ Popul Health OutcomesPublished Analysis of National Health and Nutrition Examination Survey 1999-2002 data linked to National Death Index follow-up

Main finding · All-cause mortalityResult — go to the resultHazard ratio 1.57 per 5-percentage-point increase in predicted risk 95% CI 1.45–1.70

Authors' conclusion

Biologic PREVENT variants were associated with mortality but did not improve discrimination compared with chronologic PREVENT, suggesting biological aging metrics may complement rather than replace chronological age in cardiovascular risk prediction.

Study context

Population
Adults aged 50–79 years without baseline cardiovascular disease and with DNA methylation data507 participants died, including 140 cardiovascular deaths, mean follow-up 17.35 years
Participants
1,516 adults
Exposure
Substituting epigenetic age for chronologic age within PREVENT
Outcome
All-cause mortality
Methodological detailsSurvey weighted Cox models, Weighted Harrell C statistics, 95% CIs obtained by bootstrap resampling
  • Survey weighted Cox models
  • Weighted Harrell C statistics
  • 95% CIs obtained by bootstrap resampling

Main finding

As reported in the abstract

Hazard ratio

1.57 per 5-percentage-point increase in predicted risk

95% CI 1.45–1.70

Chronologic PREVENT
HR 1.57 per 5-percentage-point increase in predicted risk (95% CI 1.45–1.70)

Per 5-percentage-point increase in predicted risk, as printed

Observational data: associations, not effects.

Further findings

OutcomeChronologic PREVENTCBiologic PREVENT variants
Discrimination for all-cause mortality (C statistic)0.74 (95% CI 0.72–0.77)C range 0.66-0.73
Discrimination for cardiovascular mortality (C statistic)0.78 (95% CI 0.73–0.84)C range 0.71-0.77

Cardiovascular mortality

Biologic variants HR range
1.47-1.67

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Assessing Differences Between Epigenetic versus Chronologic Age for Cardiovascular Risk Assessments in the United States. Circ Popul Health Outcomes. Published 31 August 2026. doi:10.1161/circoutcomes.126.013600

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.